Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy
We describe a case of a 63-year-old woman with advanced colon cancer and liver metastases who was treated with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) and cetuximab chemotherapy. She tolerated 13 cycles of chemotherapy without any significant hematological side effects, but after the 14th...
Saved in:
Main Authors: | Eric L. Tam, Padma L. Draksharam, Jennifer A. Park, Gurinder S. Sidhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/4314797 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas
by: I-Wei Ho, et al.
Published: (2024-12-01) -
Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
by: Hyun Joo Jang, et al.
Published: (2016-01-01) -
Acute Brucellosis Presenting with Bleeding Tendency due to Isolated Severe Thrombocytopenia
by: M. Aon, et al.
Published: (2018-01-01) -
Experimental Study of Irinotecan Induced Side Effects on Digestive and Immune System of Mice
by: Liya LIU, et al.
Published: (2018-04-01) -
Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
by: Hiroyuki Komori, et al.
Published: (2014-01-01)